Coherus Oncology, Inc. Increase (Decrease) in Accounts Payable, Trade
Coherus Oncology, Inc. (CHRS) reported Increase (Decrease) in Accounts Payable, Trade of $4.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-05
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $1.69M.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $2.56M, a 80.34% decline year-over-year.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$5.09M, a 180.23% decline year-over-year.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$15.30M.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$19.56M.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was -$3.94M.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for fiscal 2022 was -$4.55M, a 620.37% decline from fiscal 2021.
- Coherus Oncology, Inc. increase (decrease) in accounts payable, trade for fiscal 2021 was $874.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.25M 10-Q · filed 2026-08-05 | -$835.00K derived: sum of 3 quarters · filed 2026-08-05 | -$16.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-11 | -$2.52M derived: sum of 2 quarters · filed 2026-05-11 | -$17.82M derived: sum of 3 quarters · filed 2026-05-11 | -$30.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$20.39M derived: sum of 2 quarters · filed 2026-03-09 | -$32.60M derived: sum of 3 quarters · filed 2026-08-05 | -$19.56M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$27.51M derived: sum of 2 quarters · filed 2026-08-05 | -$14.47M 10-Q · filed 2025-11-06 | -$8.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$12.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $833.00K 10-Q · filed 2026-08-05 | $7.17M derived: sum of 3 quarters · filed 2026-08-05 | -$43.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.04M 10-Q · filed 2026-05-11 | $19.38M derived: sum of 2 quarters · filed 2026-05-11 | -$30.97M derived: sum of 3 quarters · filed 2026-05-11 | $8.49M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$44.02M derived: sum of 2 quarters · filed 2026-03-09 | -$4.55M derived: sum of 3 quarters · filed 2026-03-09 | -$3.94M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$50.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.90M derived: sum of 2 quarters · filed 2025-11-06 | -$10.28M 10-Q · filed 2025-11-06 | -$11.06M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $39.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $40.08M 10-Q · filed 2025-08-07 | $39.29M derived: sum of 3 quarters · filed 2025-11-13 | $46.05M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $616.00K 10-Q · filed 2025-05-12 | -$169.00K derived: sum of 2 quarters · filed 2025-11-13 | $6.59M derived: sum of 3 quarters · filed 2025-11-13 | $12.64M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | -$785.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | $5.97M derived: sum of 2 quarters · filed 2025-11-13 | $12.02M derived: sum of 3 quarters · filed 2025-11-13 | $23.76M 8-K · filed 2025-11-13 |
| 2023-09-30 | $6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.81M derived: sum of 2 quarters · filed 2024-11-06 | $24.55M 10-Q · filed 2024-11-06 | $26.15M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $6.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $17.79M 10-Q · filed 2024-08-08 | $19.39M derived: sum of 3 quarters · filed 2025-03-17 | $11.81M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $11.74M 10-Q · filed 2024-05-09 | $13.34M derived: sum of 2 quarters · filed 2025-03-17 | $5.77M derived: sum of 3 quarters · filed 2025-03-17 | $2.43M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$5.97M derived: sum of 2 quarters · filed 2025-03-17 | -$9.30M derived: sum of 3 quarters · filed 2025-03-17 | -$4.55M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$7.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$10.91M derived: sum of 2 quarters · filed 2023-11-06 | -$6.15M 10-Q · filed 2023-11-06 | -$35.77M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | -$3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.42M 10-Q · filed 2023-08-02 | -$28.20M derived: sum of 3 quarters · filed 2024-03-15 | $3.07M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | $4.76M 10-Q · filed 2023-05-08 | -$24.86M derived: sum of 2 quarters · filed 2024-03-15 | $6.40M derived: sum of 3 quarters · filed 2024-03-15 | $5.43M derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | -$29.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.65M derived: sum of 2 quarters · filed 2024-03-15 | $671.00K derived: sum of 3 quarters · filed 2024-03-15 | $874.00K 10-K · filed 2024-03-15 |
| 2021-09-30 | $31.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $30.29M derived: sum of 2 quarters · filed 2022-11-08 | $30.50M 10-Q · filed 2022-11-08 | $33.78M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$976.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$773.00K 10-Q · filed 2022-08-04 | $2.52M derived: sum of 3 quarters · filed 2023-03-06 | -$5.46M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $203.00K 10-Q · filed 2022-05-05 | $3.49M derived: sum of 2 quarters · filed 2023-03-06 | -$4.49M derived: sum of 3 quarters · filed 2023-03-06 | -$4.66M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$4.69M derived: sum of 2 quarters · filed 2023-03-06 | -$4.86M derived: sum of 3 quarters · filed 2023-03-06 | -$9.82M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$7.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$8.15M derived: sum of 2 quarters · filed 2021-11-08 | -$13.11M 10-Q · filed 2021-11-08 | -$1.78M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$5.13M 10-Q · filed 2021-08-05 | $6.20M derived: sum of 3 quarters · filed 2022-02-23 | $687.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$4.96M 10-Q · filed 2021-05-06 | $6.37M derived: sum of 2 quarters · filed 2022-02-23 | $860.00K derived: sum of 3 quarters · filed 2022-02-23 | $8.90M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $11.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $5.82M derived: sum of 2 quarters · filed 2022-02-23 | $13.86M derived: sum of 3 quarters · filed 2022-02-23 | $9.89M 10-K · filed 2022-02-23 |
| 2019-09-30 | -$5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.53M derived: sum of 2 quarters · filed 2020-11-05 | -$1.44M 10-Q · filed 2020-11-05 | $6.02M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $8.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.07M 10-Q · filed 2020-08-06 | $11.53M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2019-03-31 | -$3.96M 10-Q · filed 2020-05-07 | $3.49M derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$301.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$7.76M 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | -$3.81M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |